Global Continuous Glucose Monitoring Systems Market to Reach $5.6 Billion by 2027 - ResearchAndMarkets.com

The "Continuous Glucose Monitoring Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Continuous Glucose Monitoring Systems estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$5.6 Billion by 2027, growing at a CAGR of 17.6% over the analysis period 2020-2027. Sensors, one of the segments analyzed in the report, is projected to record a 16.4% CAGR and reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Transmitters & Receivers segment is readjusted to a revised 18.3% CAGR for the next 7-year period.

The U. S. Market is Estimated at $486.2 Million, While China is Forecast to Grow at 22% CAGR

The Continuous Glucose Monitoring Systems market in the U. S. is estimated at US$486.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 22% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.8% and 16.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.1% CAGR.

Integrated Insulin Pumps Segment to Record 21.3% CAGR

In the global Integrated Insulin Pumps segment, USA, Canada, Japan, China and Europe will drive the 20.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$193.9 Million in the year 2020 will reach a projected size of US$714.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$811.5 Million by the year 2027, while Latin America will expand at a 22.6% CAGR through the analysis period.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Abbott Laboratories
• DexCom, Inc.
• Medtronic PLC

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Continuous Glucose Monitoring Systems Competitor Market Share Scenario Worldwide (in %):2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/yqpaw0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200929005742/en/